Pip Deely

Making extinction a thing of the past. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

Cambrian Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to treat and ultimately prevent some of todays most debilitating chronic diseases, including platforms targeting the critical metabolic pathways that decline with age such as AMPK activation, mitochondrial function, and mTORC1 inhibition, to extend the period of life spent in good health.

Beckley Psytech is now AtaiBeckley, a global leader in transformative mental health therapies, following the successful strategic combination with atai Life Sciences. To stay up to date with all the latest news, please follow @AtaiBeckley and visit our website at www.ataibeckley.com.

Transcend Therapeutics, founded in 2021, is a clinical-stage, neuroscience-focused company developing rapid-acting treatments for neuropsychiatric diseases. Our mission is to develop new drugs for the millions of people for whom current psychiatric medicines have not worked. Our leadership team has made pivotal contributions to 13 FDA approvals (including recent MDD approval), $3.5B in M&A, and significant public company value creation. As a Public Benefit Corporation, we have pledged 10% of founding shares toward nonprofits focused on scientific research and access.

We’re a state-of-the-art medical practice with a root-cause, whole person approach and a focus on genuine doctor-patient relationships, data, and technology. Join the journey today - were hiring! Check out open roles at https://www.parsleyhealth.com/careers/

The #1 global leader in expert content for Health, Wellness, Workplace, Travel, and Education — helping 1,000+ companies. JOIN THOUSANDS OF COMPANIES Caravan has a solution for every company. We help organizations, influencers, and leaders all around the world, to increase the power of their brand, create impact opportunities, engage new audiences, and develop healthier and happier communities. Caravan is featured on the New York Times, ELLE, Yahoo, and PureWow. THE WORLDS BEST EXPERT CONTENT * Premium Production * Guided by Top Experts * Optimized for Engagement * Trusted & Tested Content * Backed by Science, Accuracy Ensured * Compliant with All Regulatory Needs TRUSTED & TESTED CONTENT * 100+ Top Certified Teachers & Experts * 2,000+ High Quality Videos & Audios * 100+ Powerful Programs * Culturally Relevant, in 15+ Languages * 1,000+ Expert Written Articles, Illustrations, And More ALL-IN-ONE SOLUTION *Medical Education *Workplace Wellness *Mental Health *Physical Health *Financial Wellness *Mindful Nutrition And so many more... We envision a world where everyone can access all the best health, fitness, and wellness practices, techniques and rituals – no matter your age, income, or location. Contact us at info@caravanwellness.com

Good Money is building modern financial products that help people achieve financial freedom, while doing good for the planet. We're a passionate team of engineers, designers, business builders, and entrepreneurs - on a mission to make money do good. If you're looking to join an all-star team that's building at the bleeding edge of a once-in-a-generation opportunity to invent the future of consumer financial services, look no further - we're hiring! *** Good Money's co-founders have a track record of scaling high-growth companies in the D2C, Consumer Software, and B2B/SaaS verticals that have generated $1.5B+ in revenue and scaled to tens of millions of users. To date, Good Money has raised $30M+ in funding from top fintech and impact investors including Galaxy Digital, Blocktower Capital, Blockchange, Boost, Breyer Capital, Cervin Ventures, CUNA Mutual, Designer Fund, M13, Morgan Creek Digital, MS&AD Ventures, SVB, Uprising VC, and WTI.

Our Product: Datavore is an adaptive data analytics platform that allows you to quickly explore your datasets and ask meaningful questions. Our intuitive interface enables you to easily create repeatable workflows for data aggregation, normalization, analysis, and visualization. Our Team: The Datavore team has deep domain expertise in databases, time series, and analytics with a successful track record of building technology within the financial services sector. The team has experience working at companies including Goldman Sachs, Citigroup, UBS, Thomson Reuters, Ernst & Young, and KPMG.

Smallhold is on a mission to dramatically shorten the distance between you and fresh, gourmet mushrooms. Our growing network of organic farms is upending the traditional farming model with patented technology and a sophisticated supply chain, dramatically increasing access to freshly harvested mushrooms. You can find Smallhold in places like Whole Foods, Central Market, FreshDirect, farmers markets, and more. You can watch our mushrooms grow in tech-enabled minifarms inside restaurants, grocery stores, and nonprofits, or even on your own kitchen counter with one of our home grow kits, available at smallhold.com.

Imperfect Foods was founded in 2015 with a mission to reduce food waste and build a better food system for everyone. We offer imperfect (yet delicious) produce, affordable pantry items, and quality meat and dairy. We deliver them conveniently to our customers’ doorsteps and pride ourselves on offering up to a 30% discount compared to grocery store prices. Our customers can get the healthy, seasonal produce they want alongside the grocery staples they rely on, without having to compromise their budget or values. We’re proving that doing the right thing for the planet doesn’t have to cost more, and that shopping for quality ingredients can support the people and resources that it takes to grow our favorite foods. Were headquartered in San Francisco with operations all over the country. Check our website to see if there is an Imperfect near you! Were looking for folks who are positive, motivated, and ready to change the world. If that sounds like you, drop us a line!

Making extinction a thing of the past. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

Cambrian Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to treat and ultimately prevent some of todays most debilitating chronic diseases, including platforms targeting the critical metabolic pathways that decline with age such as AMPK activation, mitochondrial function, and mTORC1 inhibition, to extend the period of life spent in good health.

Beckley Psytech is now AtaiBeckley, a global leader in transformative mental health therapies, following the successful strategic combination with atai Life Sciences. To stay up to date with all the latest news, please follow @AtaiBeckley and visit our website at www.ataibeckley.com.

Transcend Therapeutics, founded in 2021, is a clinical-stage, neuroscience-focused company developing rapid-acting treatments for neuropsychiatric diseases. Our mission is to develop new drugs for the millions of people for whom current psychiatric medicines have not worked. Our leadership team has made pivotal contributions to 13 FDA approvals (including recent MDD approval), $3.5B in M&A, and significant public company value creation. As a Public Benefit Corporation, we have pledged 10% of founding shares toward nonprofits focused on scientific research and access.

We’re a state-of-the-art medical practice with a root-cause, whole person approach and a focus on genuine doctor-patient relationships, data, and technology. Join the journey today - were hiring! Check out open roles at https://www.parsleyhealth.com/careers/